pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 25·1 min read
save

Tobacco companies submitted 175,000 largely duplicate comments to block FDA menthol cigarette ban

Sep 25, 2026·read at STAT ↗RegulatoryNegative

Researchers at Rutgers University analyzed the public comment period for the FDA’s 2022 proposal to ban menthol cigarettes and found that out of 175,000 submissions, 97% were form letters and only about 2% were unique.

Nearly half of the letters repeated language used in campaigns by Altria Group or Reynolds American, and the remainder echoed common industry talking points.

The practice of flooding regulators with near‑identical comments dates back to the 1980s, when the tobacco sector opposed airline smoking restrictions.

The overwhelming volume of duplicate comments is cited as a factor in the FDA’s decision to abandon the menthol ban proposal.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “How Big Tobacco flooded the FDA with public comments to kill a menthol cigarette ban”

read at STAT ↗
1,369 words · retrieved Sep 25
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
UNIQUE2Jazz Pharmaceuticals plc

related stories

  • Jul 21The FDA’s 505(b)(2) pathway is an underestimated engine of value creationBioSpace
  • Jun 1Opinion: The military’s medical corps has a serious recruitment problemSTAT
  • Jun 1The hidden history of BPC-157, a favorite MAHA peptideSTAT
  • May 29Pfizer, Innovent strike $10B cancer drug dealBioPharma Dive
  • May 18Unlocking more value from mature drug products through strategic outsourcingBioPharma Dive